Kerry Group Buys Novozymes, Chr. Hansen Assets for EUR150 Million
By Christian Moess Laursen
Kerry Group has bought assets from Danish biotechnology companies Novozymes and Chr. Hansen for a total consideration of 150 million euros ($161.5 million).
The deal--expected to close in the first half of 2024--comprises certain trade and assets of Chr. Hansen's global lactase enzyme business and the entire share capital of Nuocheng Trillion Food, a Chinese subsidiary of Novozymes.
The Ireland-based food company said Tuesday that the acquisition improves its ability to create biotechnology solutions following acquisitions of c-LEcta and Enmex in 2022 and 2021, respectively.
It is subject to the European Commission's approval of Kerry as a buyer, and forms part of the Novozymes and Chr. Hansen merger-approval process. Earlier today, the executive arm of the EU conditionally approved the merger.
The assets have attributable revenue around EUR40 million in 2022, with sales in more than 50 countries, Kerry Group said.
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
December 12, 2023 12:06 ET (17:06 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks